Tissue-specific and ubiquitous expression patterns from alternative promoters of human genes.
BACKGROUND
Transcriptome diversity provides the key to cellular identity. One important contribution to expression diversity is the use of alternative promoters, which creates mRNA isoforms by expanding the choice of transcription initiation sites of a gene. The proximity of the basal promoter to the transcription initiation site enables prediction of a promoter's location based on the gene annotations. We show that annotation of alternative promoters regulating expression of transcripts with distinct first exons enables a novel methodology to quantify expression levels and tissue specificity of mRNA isoforms.


RESULTS
The use of distinct alternative first exons in 3,296 genes was examined using exon-microarray data from 11 human tissues. Comparing two transcripts from each gene we found that the activity of alternative promoters (i.e., P1 and P2) was not correlated through tissue specificity or level of expression. Furthermore neither P1 nor P2 conferred any bias for tissue-specific or ubiquitous expression. Genes associated with specific diseases produced transcripts whose limited expression patterns were consistent with the tissue affected in disease. Notably, genes that were historically designated as tissue-specific or housekeeping had alternative isoforms that showed differential expression. Furthermore, only a small number of alternative promoters showed expression exclusive to a single tissue indicating that "tissue preference" provides a better description of promoter activity than tissue specificity. When compared to gene expression data in public databases, as few as 22% of the genes had detailed information for more than one isoform, whereas the remainder collapsed the expression patterns from individual transcripts into one profile.


CONCLUSIONS
We describe a computational pipeline that uses microarray data to assess the level of expression and breadth of tissue profiles for transcripts with distinct first exons regulated by alternative promoters. We conclude that alternative promoters provide individualized regulation that is confirmed through expression levels, tissue preference and chromatin modifications. Although the selective use of alternative promoters often goes uncharacterized in gene expression analyses, transcripts produced in this manner make unique contributions to the cell that requires further exploration.
Jacox
Edwin
E
National Human Genome Research Institute, National Institutes of Health, Rockville, Maryland, United States of America.
Gotea
Valer
V
Ovcharenko
Ivan
I
Elnitski
Laura
L
D019295:Computational Biology; D030541:Databases, Genetic; D004194:Disease / Q000235:genetics; D019277:Entropy; D044127:Epigenesis, Genetic / Q000235:genetics; D005091:Exons / Q000235:genetics; D020869:Gene Expression Profiling; D023281:Genomics; D051557:Hepatocyte Nuclear Factor 4 / Q000235:genetics; D006801:Humans; D009154:Mutation; D009693:Nucleic Acid Hybridization; D020411:Oligonucleotide Array Sequence Analysis; D009928:Organ Specificity; D010641:Phenotype; D011401:Promoter Regions, Genetic / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics
C496592:HNF4A protein, human; D051557:Hepatocyte Nuclear Factor 4; D012333:RNA, Messenger
Cell. 2007 Feb 23;128(4):707-19
17320508
Trends Genet. 2003 Jul;19(7):362-5
12850439
Diabetes. 2008 Jun;57(6):1745-52
18356407
Lipids Health Dis. 2008 Jul 24;7:25
18652652
Cell. 2006 Jul 14;126(1):37-47
16839875
Genome Biol. 2009;10(4):R39
19374773
Semin Immunopathol. 2009 Sep;31(3):333-43
19639317
Biochim Biophys Acta. 2001 May 31;1532(1-2):105-14
11420179
Cell Mol Life Sci. 2003 Aug;60(8):1647-58
14504655
Annu Rev Biochem. 2003;72:449-79
12651739
Trends Genet. 2008 Apr;24(4):167-77
18329129
Genome Res. 2007 Jun;17(6):669-81
17567988
Science. 2001 Feb 16;291(5507):1284-9
11181991
J Comput Biol. 2004;11(2-3):377-94
15285897
Nat Genet. 2004 Jan;36(1):40-5
14702039
Cell Cycle. 2009 Sep 15;8(18):2895-900
19736519
Biochim Biophys Acta. 2007 Nov;1768(11):2690-7
17692818
Oncogene. 2004 Jul 15;23(32):5551-7
15077175
Trends Genet. 2003 Feb;19(2):68-72
12547512
Science. 1997 Sep 5;277(5331):1497-501
9278511
Proc Natl Acad Sci U S A. 2007 May 8;104(19):8005-10
17463089
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6062-7
15075390
Circ Res. 1998 Oct 19;83(8):860-9
9776733
Genome Res. 2007 Feb;17(2):145-55
17210929
J Exp Med. 1977 Aug 1;146(2):629-30
327019
Brain Res Mol Brain Res. 1994 Jan;21(1-2):1-8
8164510
Genome Res. 2006 Jan;16(1):55-65
16344560
J Immunol. 2008 Aug 1;181(3):2010-8
18641338
Hum Mol Genet. 2001 Apr;10(7):663-7
11257097
J Mol Diagn. 2003 Feb;5(1):9-14
12552074
Nat Genet. 2006 Jun;38(6):626-35
16645617
Mol Cells. 2009 Aug 31;28(2):111-7
19669628
Nat Genet. 2007 Oct;39(10):1217-24
17873874
Trends Genet. 2003 Nov;19(11):640-8
14585616
Cell. 2007 May 18;129(4):823-37
17512414
Drug Metab Pharmacokinet. 2007 Jun;22(3):152-61
17603215
EMBO J. 2006 Mar 22;25(6):1253-62
16498401
Endocrinology. 2003 May;144(5):1686-94
12697672
Genome Biol. 2005;6(4):R33
15833120
Genome Res. 2005 Jul;15(7):1007-14
15998913
Mol Cell. 1998 Sep;2(3):305-16
9774969
Cell Signal. 2006 Sep;18(9):1408-16
16431080
Genome Res. 2007 Jul;17(7):1005-14
17567985
Diabetes Metab Res Rev. 2007 Jan;23(1):21-5
16572495
Nature. 2010 Jul 8;466(7303):253-7
20613842
J Biol Chem. 2004 Aug 6;279(32):33398-408
15159395